is tirzepatide a dual agonist and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports Retatrutide vs Tirzepatide (Research Comparison)

Specialist consultation included

Microdosing is beneficial for those who want to achieve slower weight loss or glycemic control, along with potential metabolic benefits

Future regulatory developmentsespecially if the FDA and NIH increase flexibility around novel addiction treatmentscould open additional pathways

"Theres a real opportunity and need to provide free nutrition guidance and content to educate a growing population of people accessing GLP-1 medications for weight loss so they have long-term, sustainable outcomes." Mike Fisher, CEO, MyFitnessPal Smart devices like wearables and scales that sync with platforms like Apple Health or Google Fit can further simplify tracking